Evidence map›Paper›PMID 37260735›Full record

ArticleMass spectrometry (Tokyo, Japan)2023

Immuno-Mass Spectrometry Workflow for Quantification of Serum α-Fetoprotein Using Antibody-Immobilized Magnetic Beads and Modified Eluents.

Yoshio Takahata, Misato Hara, Kouhei Nishino, Takao Kawakami

Open access · diamondAbstract read
In one paragraph

Article in Mass spectrometry (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yoshio TakahataBiomolecule Analysis Group, Medical ProteoScope Co., Ltd., Yokohama Kanazawa High-Tech Center Techno Core, 1-1-1 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
Misato HaraTamagawa Seiki Co., Ltd., 1879 Ohyasumi, Iida, Nagano 395-8515, Japan.
Kouhei NishinoBiomolecule Analysis Group, Medical ProteoScope Co., Ltd., Yokohama Kanazawa High-Tech Center Techno Core, 1-1-1 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
Takao KawakamiBiomolecule Analysis Group, Medical ProteoScope Co., Ltd., Yokohama Kanazawa High-Tech Center Techno Core, 1-1-1 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
Laboratoire des Biomolécules · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immuno-mass spectrometry (MS) is a powerful method for the quantitative analysis of low-abundance proteins in biological specimens. In these procedures, collecting specifically and efficiently the target protein antigens from the antigen-antibody complex generated on the surface of nanocarrier beads is crucial and can be performed by hydrolyzing the proteins directly on the beads or after elution. Herein, we optimized the conditions of the immunoaffinity purification via elution using serum α-fetoprotein (AFP) as a model and its specific antibody immobilized covalently on magnetic beads. Antibody-coated beads were incubated with human serum spiked with standard AFP for antigen-antibody reaction. AFP was then eluted from the beads using various eluents, including organic solvents, to optimize the elution conditions. After proteolytically hydrolyzing the eluted protein, stable isotope-labeled standard peptides were added to the hydrolysate to quantify the eluted AFP

Indexed as

absolute protein quantitationAFPimmuno-MSLC–MS/MSα-fetoprotein

Identifiers

PMID37260735
PMCPMC10227195
OpenAlexW4367728931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.